403 related articles for article (PubMed ID: 21082279)
1. The H9C2 cell line and primary neonatal cardiomyocyte cells show similar hypertrophic responses in vitro.
Watkins SJ; Borthwick GM; Arthur HM
In Vitro Cell Dev Biol Anim; 2011 Feb; 47(2):125-31. PubMed ID: 21082279
[TBL] [Abstract][Full Text] [Related]
2. Gram-negative endotoxin lipopolysaccharide induces cardiac hypertrophy: detrimental role of Na(+)-Ca(2+) exchanger.
Magi S; Nasti AA; Gratteri S; Castaldo P; Bompadre S; Amoroso S; Lariccia V
Eur J Pharmacol; 2015 Jan; 746():31-40. PubMed ID: 25445045
[TBL] [Abstract][Full Text] [Related]
3. Isoproterenol-induced hypertrophy of neonatal cardiac myocytes and H9c2 cell is dependent on TRPC3-regulated Ca
Han JW; Kang C; Kim Y; Lee MG; Kim JY
Cell Calcium; 2020 Dec; 92():102305. PubMed ID: 33069962
[TBL] [Abstract][Full Text] [Related]
4. An autocrine role for leptin in mediating the cardiomyocyte hypertrophic effects of angiotensin II and endothelin-1.
Rajapurohitam V; Javadov S; Purdham DM; Kirshenbaum LA; Karmazyn M
J Mol Cell Cardiol; 2006 Aug; 41(2):265-74. PubMed ID: 16806260
[TBL] [Abstract][Full Text] [Related]
5. Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators.
Johns DG; Ao Z; Naselsky D; Herold CL; Maniscalco K; Sarov-Blat L; Steplewski K; Aiyar N; Douglas SA
Naunyn Schmiedebergs Arch Pharmacol; 2004 Oct; 370(4):238-50. PubMed ID: 15549273
[TBL] [Abstract][Full Text] [Related]
6. Cardiomyocyte-specific transgenic expression of lysyl oxidase-like protein-1 induces cardiac hypertrophy in mice.
Ohmura H; Yasukawa H; Minami T; Sugi Y; Oba T; Nagata T; Kyogoku S; Ohshima H; Aoki H; Imaizumi T
Hypertens Res; 2012 Nov; 35(11):1063-8. PubMed ID: 22763477
[TBL] [Abstract][Full Text] [Related]
7. The POU4F2/Brn-3b transcription factor is required for the hypertrophic response to angiotensin II in the heart.
Mele L; Maskell LJ; Stuckey DJ; Clark JE; Heads RJ; Budhram-Mahadeo VS
Cell Death Dis; 2019 Aug; 10(8):621. PubMed ID: 31413277
[TBL] [Abstract][Full Text] [Related]
8. COX-2 is involved in ET-1-induced hypertrophy of neonatal rat cardiomyocytes: role of NFATc3.
Li H; Gao S; Ye J; Feng X; Cai Y; Liu Z; Lu J; Li Q; Huang X; Chen S; Liu P
Mol Cell Endocrinol; 2014 Feb; 382(2):998-1006. PubMed ID: 24291639
[TBL] [Abstract][Full Text] [Related]
9. The effect of intermedin on angiotensin II and endothelin-1 induced ventricular myocyte hypertrophy in neonatal rat.
Liu K; Deng X; Gong L; Chen X; Wang S; Chen H; Chen X; Amrit B; He S
Clin Lab; 2013; 59(5-6):589-96. PubMed ID: 23865358
[TBL] [Abstract][Full Text] [Related]
10. High content screening identifies licoisoflavone A as a bioactive compound of Tongmaiyangxin Pills to restrain cardiomyocyte hypertrophy via activating Sirt3.
Guo R; Liu N; Liu H; Zhang J; Zhang H; Wang Y; Baruscotti M; Zhao L; Wang Y
Phytomedicine; 2020 Mar; 68():153171. PubMed ID: 32018211
[TBL] [Abstract][Full Text] [Related]
11. 3,3'-Diindolylmethane attenuates cardiac H9c2 cell hypertrophy through 5'-adenosine monophosphate-activated protein kinase-α.
Zong J; Wu QQ; Zhou H; Zhang JY; Yuan Y; Bian ZY; Deng W; Dai J; Li FF; Xu M; Fang Y; Tang QZ
Mol Med Rep; 2015 Jul; 12(1):1247-52. PubMed ID: 25816057
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-29a-3p attenuates ET-1-induced hypertrophic responses in H9c2 cardiomyocytes.
Li M; Wang N; Zhang J; He HP; Gong HQ; Zhang R; Song TF; Zhang LN; Guo ZX; Cao DS; Zhang TC
Gene; 2016 Jul; 585(1):44-50. PubMed ID: 26992639
[TBL] [Abstract][Full Text] [Related]
13. [Protein kinase Cdelta is possibly involved in the transition from hypertrophy to apoptosis of myocardiocytes].
Guo WG; Yu ZB; Xie MJ
Sheng Li Xue Bao; 2006 Jun; 58(3):269-74. PubMed ID: 16786112
[TBL] [Abstract][Full Text] [Related]
14. Endothelin-1-induced hypertrophic alterations and heme oxygenase-1 expression in cardiomyoblasts are counteracted by beta estradiol: in vitro and in vivo studies.
Barta T; Tosaki A; Haines D; Balla G; Lekli I; Tosaki A
Naunyn Schmiedebergs Arch Pharmacol; 2018 Apr; 391(4):371-383. PubMed ID: 29354880
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor delta agonists attenuated the C-reactive protein-induced pro-inflammation in cardiomyocytes and H9c2 cardiomyoblasts.
Liang YJ; Chen CY; Juang SJ; Lai LP; Shyu KG; Wang BW; Liu SY; Leu JG
Eur J Pharmacol; 2010 Sep; 643(1):84-92. PubMed ID: 20599914
[TBL] [Abstract][Full Text] [Related]
16. Hexarelin protects cardiac H9C2 cells from angiotensin II-induced hypertrophy
Agbo E; Li MX; Wang YQ; Saahene RO; Massaro J; Tian GZ
Pharmazie; 2019 Aug; 74(8):485-491. PubMed ID: 31526442
[TBL] [Abstract][Full Text] [Related]
17. Evidence that apoptotic signalling in hypertrophic cardiomyocytes is determined by mitochondrial pathways involving protein kinase Cδ.
Xie MJ; Chang H; Wang YY; Zhang L; Song Z; Guo WG; Wang T; Che HL; Yu ZB
Clin Exp Pharmacol Physiol; 2010 Dec; 37(12):1120-8. PubMed ID: 20880184
[TBL] [Abstract][Full Text] [Related]
18. Soluble epoxide hydrolase inhibitor, TUPS, attenuates isoproterenol/angiotensin II-induced cardiac hypertrophy through mammalian target of rapamycin-mediated autophagy inhibition.
Zhang H; Zhang K; Liang J; Yan W; Wu F; Xu W; Wu Z; Chen Y; Pan R; Wu G
J Pharm Pharmacol; 2019 Aug; 71(8):1291-1300. PubMed ID: 31215026
[TBL] [Abstract][Full Text] [Related]
19. Eicosapentaenoic acid prevents endothelin-1-induced cardiomyocyte hypertrophy in vitro through the suppression of TGF-beta 1 and phosphorylated JNK.
Shimojo N; Jesmin S; Zaedi S; Maeda S; Soma M; Aonuma K; Yamaguchi I; Miyauchi T
Am J Physiol Heart Circ Physiol; 2006 Aug; 291(2):H835-45. PubMed ID: 16501010
[TBL] [Abstract][Full Text] [Related]
20. OBG-like ATPase 1 inhibition attenuates angiotensin II-induced hypertrophic response in human ventricular myocytes via GSK-3beta/beta-catenin signalling.
Narasimhan G; Henderson J; Luong HT; Rajasekaran NS; Qin G; Zhang J; Krishnamurthy P
Clin Exp Pharmacol Physiol; 2019 Aug; 46(8):743-751. PubMed ID: 31063653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
